← Back to Clinical Trials
Recruiting NCT06874868

Salivary Cortisol As a Biomarker in Patients with Temporomandibular Disorder

Trial Parameters

Condition Temporomandibular Joint Disorder
Sponsor University of Coimbra
Study Type OBSERVATIONAL
Phase N/A
Enrollment 50
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-09-15
Completion 2024-09-20

Brief Summary

t is recognized that cortisol, a hormone produced by the adrenal glands, is a marker that is elevated in patients with psychological disorders, particularly anxiety. On the other hand, Temporomandibular Disorders (TMD) are a condition with a multifactorial etiology, in which emotional disturbances play a crucial role. Therefore, the aim of this study is to evaluate whether patients with TMD have higher levels of salivary cortisol compared to the general population. Initially, an assessment will be conducted using the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) protocol to determine whether the patient suffer of any kind of Temporomandibular Disorder. Based on the results, individuals will be classified into two groups: the study group, consisting of patients with TMD, and the control group, composed of individuals without the disorder. Those who agree to participate will be required to sign an informed consent form. Subsequently, a saliva sample will be collected for analysis.

Eligibility Criteria

Inclusion Criteria: * Patients who attend the dental clinic of the Faculty of Medicine of University of Coimbra Exclusion Criteria: * Pregnant women, minors and non-autonomous individuals

Related Trials